Development of a prostate cancer PDX model radioresistant to PSMA targeted radionuclide therapy

被引：0
|
作者：
Thaysen, Maria
Christensen, Esben
Nielsen, Rikke N.
Wick, Michael
Wessel, Mette M.
Kristensen, Lotte K.
Gnosa, Sebastian
Nielsen, Carsten H.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5039
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
    Iagaru, Andrei H.
    Mittra, Erik
    Colletti, Patrick M.
    Jadvar, Hossein
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 19S - 24S
  • [32] Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy
    Xu, Jing
    Yu, Jingmou
    Xu, Xiao
    Wang, Liangliang
    Liu, Yonghua
    Li, Lixin
    Zhao, Jianguo
    He, Ming
    JOURNAL OF NANOMATERIALS, 2014, 2014
  • [33] Combination therapy of benfo-oxythiamine and Luetium-177-PSMA radionuclide therapy in a preclinical prostate cancer model
    Wolfshoefer, S.
    Gast, M.
    Beindorff, N.
    Stintzing, S.
    Baum, R. P.
    Grabowski, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S467 - S467
  • [34] The potential of PSMA-targeted alpha therapy in the management of prostate cancer
    Filippi, Luca
    Chiaravalloti, Agostino
    Schillaci, Orazio
    Bagni, Oreste
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (10) : 823 - 829
  • [35] Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer
    Damiana, Tyrillshall S. T.
    Dalm, Simone U.
    PHARMACEUTICS, 2021, 13 (05)
  • [36] 213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
    Mike Sathekge
    Otto Knoesen
    Marian Meckel
    Moshe Modiselle
    Mariza Vorster
    Sebastian Marx
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1099 - 1100
  • [37] 213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
    Sathekge, Mike
    Knoesen, Otto
    Meckel, Marian
    Modiselle, Moshe
    Vorster, Mariza
    Marx, Sebastian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (06) : 1099 - 1100
  • [38] PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer
    Huangfu, Zhenyuan
    Yang, Jiangtao
    Sun, Juan
    Xu, Bin
    Tao, Lei
    Wu, Jiang
    Wang, Feng
    Wang, Guanglin
    Meng, Fenghua
    Zhong, Zhiyuan
    JOURNAL OF CONTROLLED RELEASE, 2024, 375 : 767 - 775
  • [39] Evaluation of [68Ga]Ga-PSMA-PET/CT in therapy response assessment of PSMA-targeted radionuclide therapy in patients with castration resistant prostate cancer
    Kurth, J.
    Kretzschmar, J.
    Heuschkel, M.
    Kundt, G.
    Hakenberg, O. W.
    Krause, B. J.
    Schwarzenboeck, S. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S26 - S26
  • [40] Development of PSMA-Targeted Oncolytic Adenovirus for Treatment of Prostate Cancer
    Sato-Dahlman, Mizuho
    Hajeri, Praveensingh B.
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    MOLECULAR THERAPY, 2023, 31 (04) : 674 - 674
12345